Andrea Teixeira da Cunha is an invited assistant professor of Biochemistry and Organic chemistry at Vale do Ave¿s and Vale do Sousa¿s Higher Health Schools (ESSVA and ESSVS) and at IUCS/CESPU. She has a Degree in Biochemistry , a MSc degree in Molecular Therapies (IUCS/CESPU, 2013) and a PhD degree in Biomedical Sciences (IUCS/CESPU, 2022). Within the scope of her MSc thesis, she focused her research on the functional and population analysis of genetic polymorphisms affecting genes involved in drug metabolism and transport, namely those encoding for cytochrome P450 CYP2C19 and CYP2D6 enzymes, and MDR1, encoding for P-glycoprotein. These polymorphisms may affect the efficacy of pharmacotherapy, as well as the susceptibility to certain diseases, including cancer. Andrea is currently integrated in the research group of the Oral Pathology and Rehabilitation Research Unit (UNIPRO/CESPU) and her research is focused on understanding the relationship between the microenvironment and the metabolism of tumor cells. Since tumor cells are particularly dependent on glycolysis, glycolytic inhibitors arise as promising strategies to selectively interfere with energy metabolism and lactate production, which, in turn, also affects tumor microenvironment Within the scope of her research work, she has performed poster communications and oral communications in national and international scientific meetings, which led to a proceedings publication.
Andrea Teixeira da Cunha is an invited assistant professor of Biochemistry and Organic chemistry at Vale do Ave¿s and Vale do Sousa¿s Higher Health Schools (ESSVA and ESSVS) and at IUCS/CESPU. She has a Degree in Biochemistry , a MSc degree in Molecular Therapies (IUCS/CESPU, 2013) and a PhD degree in Biomedical Sciences (IUCS/CESPU, 2022). Within the scope of her MSc thesis, she focused her research on the functional and population analysis of genetic polymorphisms affecting genes involved in drug metabolism and transport, namely those encoding for cytochrome P450 CYP2C19 and CYP2D6 enzymes, and MDR1, encoding for P-glycoprotein. These polymorphisms may affect the efficacy of pharmacotherapy, as well as the susceptibility to certain diseases, including cancer. Andrea is currently integrated in the research group of the Oral Pathology and Rehabilitation Research Unit (UNIPRO/CESPU) and her research is focused on understanding the relationship between the microenvironment and the metabolism of tumor cells. Since tumor cells are particularly dependent on glycolysis, glycolytic inhibitors arise as promising strategies to selectively interfere with energy metabolism and lactate production, which, in turn, also affects tumor microenvironment Within the scope of her research work, she has performed poster communications and oral communications in national and international scientific meetings, which led to a proceedings publication.
PhD Member